JAVELIN Renal 101 trial: avelumab and axitinib for advanced renal cell carcinoma

Bookmark and Share
Published: 21 Oct 2018
Views: 2557
Dr Robert J. Motzer - Memorial Sloan-Kettering Cancer Center, New York, USA

Dr Robert J. Motzer speaks at the ESMO 2018 congress about avelumab axitinib vs sunitinib as first-line treatment of advanced renal cell carcinoma.

To watch his interview with ecancer click here.